Spectrum Pharmaceuticals Inc
SPPI
SPPI was delisted on the 31st of July, 2023.
190 hedge funds and large institutions have $1.51B invested in Spectrum Pharmaceuticals Inc in 2018 Q3 according to their latest regulatory filings, with 34 funds opening new positions, 76 increasing their positions, 49 reducing their positions, and 22 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
55% more repeat investments, than reductions
Existing positions increased: 76 | Existing positions reduced: 49
55% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 22
18% more call options, than puts
Call options by funds: $21.9M | Put options by funds: $18.5M
6% more funds holding
Funds holding: 180 → 190 (+10)
20% less capital invested
Capital invested by funds: $1.87B → $1.51B (-$365M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
+$50.5M |
| 2 |
O
OrbiMed
New York
|
+$49M |
| 3 |
BlackRock
New York
|
+$28M |
| 4 |
Primecap Management
Pasadena,
California
|
+$22.4M |
| 5 |
State Street
Boston,
Massachusetts
|
+$15.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACA
Avoro Capital Advisors
New York
|
-$71.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$50.5M |
| 3 |
Renaissance Technologies
New York
|
-$40.4M |
| 4 |
CCM
Consonance Capital Management
New York
|
-$24.5M |
| 5 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$15.1M |
SPPI Hedge Fund Activity: Q3 2018 in Review
190 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Spectrum Pharmaceuticals Inc (SPPI) for Q3 2018, worth a combined $1.51B — down 20% from $1.87B a quarter earlier.
Buyers outnumbered sellers: 34 funds opened new SPPI positions and 22 closed out — a net gain of 12 holders — while 76 added to existing stakes and 49 trimmed.
The largest buyer was ArrowMark Colorado Holdings, adding an estimated $50.5M. The largest seller was Avoro Capital Advisors, exiting entirely with an estimated $71.7M sold.
- 190 institutional investors held Spectrum Pharmaceuticals Inc (SPPI) as of Q3 2018, up from 180 in Q2 2018.
- Funds reported $1.51B of Spectrum Pharmaceuticals Inc stock for Q3 2018, down 20% quarter-over-quarter.
- 34 funds opened new Spectrum Pharmaceuticals Inc positions in Q3 2018 and 22 closed out, a net change of +12 holders.
- The largest Spectrum Pharmaceuticals Inc buyer in Q3 2018 was ArrowMark Colorado Holdings, an estimated $50.5M added.
- The largest Spectrum Pharmaceuticals Inc seller in Q3 2018 was Avoro Capital Advisors, an estimated $71.7M sold.
Based on aggregated 13F filings for Q3 2018.